Skip to main content
. 2014 Aug;7(5):264–270.

Table.

Study Population Characteristics

Characteristic Year 1: 2009 (N = 359) Year 2: 2010 (N = 395) Year 3: 2011 (N = 365) Year 4: 2012 (N = 423)
Age at first claim, mean (SD) 71 (7.7) 71 (6.6) 70 (6.9) 71 (6.9)
Female, % 43.7 42.5 37.3 45.4
Caucasian, % 77.2 83.8 81.9 83.7
Dual-eligible for Medicare + Medicaid, % 0.6 1.3 1.9 1.7
Low-income subsidy, % 17.0 18.7 17.5 18.0
Geographic region
Northeast, % 1.9 1.0 1.1 1.7
Midwest, % 24.2 22.3 20.5 23.4
South, % 62.7 68.9 69.9 65.7
West, % 11.1 7.8 8.5 9.2
Primary treatment
Leucovorin only, N (%) 326 (90.8) 364 (92.2) 279 (76.4) 294 (69.5)
Levoleucovorin only, N (%) 6 (1.7) 3 (0.8) 27 (7.4) 76 (18.0)
Mixed treatment, N (%) 27 (7.5) 28 (7.1) 59 (16.2) 53 (12.5)

SD indicates standard deviation.